Wall Street's expectations appear to be that the company's slower-than-average growth is going to continue over the next few years. The problem in Starboard's view is that Kenvue's skin and beauty ...

Kenvue owns a strong portfolio of household brands like Tylenol, Benadryl and Band-Aid. Read why I continue to rate KVUE ...

Kenvue is guiding for $1.10 to $1.20 in 2024 earnings per share and 2% to 4% organic sales growth. If it achieves the ...

GM’s strong quarterly report included revised guidance. Strong earnings and a bullish forecast boosted Tesla shares. UPS and ...

For used cars, the average listing price is now $25,361, according to the latest report from Cox Automotive, a giant jump ...

On Oct. 21, news broke that Starboard Value took a position in Kenvue. The firm thinks there is an opportunity to improve ...

On Tuesday, the Journal reported that fellow discount airline Frontier Airlines is exploring a renewed bid for Spirit, and ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

The growth rate of the consumer healthcare business could accelerate now that an activist investor is involved.

Activist investor Elliott Investment Management and Southwest Airlines are close to a settlement deal that would give the ...